Brought to you by 
GelTex buys SunPharm for $16.5mm
08 Sep 1999
Executive Summary
GelTex Pharmaceuticals (developing non-absorbable polymer-based drugs) is acquiring SunPharm (therapeutics based on polyamine and iron chelators) for $16.5mm in GelTex common stock. For each of their shares, SunPharm shareholders are getting stock worth about $2.10 , a (pr)68% premium to its own stock's 10-day pre-announcement average of $1.25.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
GelTex buys SunPharm for $16.5mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice